China NMPA Product Recall - Acetate file

On December 26, 2019, Zimmer Biomet (Shanghai) Medical International Trading Co., Ltd. commenced a voluntary Class II recall concerning certain batches of its hip surgery tools. This significant action was publicly reported by the National Medical Products Administration (NMPA) and specifically sourced from the Shanghai Municipal Drug Administration Website. The core issue driving this recall involves a potential manufacturing defect in acetabular reamers, where the end of the rod may not properly mate with the medullary reamer. This critical defect could compromise the functionality of the tools during hip surgical procedures, potentially leading to adverse patient outcomes. Operating under the stringent regulatory framework overseen by the NMPA, which is responsible for ensuring the safety and efficacy of medical devices in China, Zimmer Biomet (Shanghai) Medical International Trading Co., Ltd. initiated this recall as a required corrective action. A Class II recall signifies that the product may cause temporary or reversible adverse health consequences, or that the probability of serious adverse health consequences is remote. The company's immediate action involves the removal of the affected devices from distribution and use. Comprehensive details, including specific product models, specifications, and batch numbers, are provided in the accompanying 'Medical Device Recall Event Report Form' to facilitate the return and management of the affected instruments. This voluntary recall underscores the company's commitment to patient safety and compliance with national medical device regulations.